Latest / Innovation and Private Capital x aulium
How Do You Turn Fat Into Bone and Avoid Amputations? - Denis Dufrane (Novadip)
How do you take a stem cell therapy from a hospital's compassionate-use program to patients worldwide, while keeping investors, regulators, and ethics aligned over a decade or more?
Denis Dufrane of Novadip Biosciences walks through that path, from university research and hospital exemptions to a spin-out built on patents and Series A and B funding. The conversation covers why a first-in-class therapy for ultra-rare pediatric bone indications is being developed in the US and Europe in parallel, and how repeated FDA interactions are used to de-risk a submission planned for the end of 2027. It…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.